Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex & ORCID
How has Li Yu's publication output changed over time?
ScholarIQpublication output · 2000–2022
Output declined50% over the shown period — from 2 works in 2000 to 1 in 2022.
2
1
1
1
2
1
1
1
1
200020022005200720102011201220152022
What are the most-cited papers on Li Yu?
ScholarIQmost cited works
Aberrant CpG-island methylation has non-random and tumour-type–specific patterns
J Costello, Michael C. Frühwald, Dominic J. Smiraglia, Laura J. Rush, Gavin P. Robertson, Xīn Gào, Fred A. Wright, Jamison D. Feramisco, Païvi Peltomäki, James C. Lang, David E. Schuller, Li Yu, Clara D. Bloomfield, Michael A. Caligiuri, Allan J. Yates, Ryo Nishikawa, H.-J. Su Huang, Nicholas J. Petrelli, Xueli Zhang, M. Sue O’Dorisio, William A. Held, Webster K. Cavenee, Christoph Plass
S137905309. 20001,366 Citations
Evaluation of the Proteasome Inhibitor MLN9708 in Preclinical Models of Human Cancer
Erik Kupperman, Edmund C. Lee, Yueying Cao, Bret Bannerman, Michael Fitzgerald, Allison Berger, Jie Yu, Yang Yu, Paul Hales, Frank J. Bruzzese, Jane Liu, Jonathan L. Blank, Khristofer Garcia, Christopher Tsu, Larry Dick, Paul Fleming, Li Yu, Mark Manfredi, Mark Rolfe, Joe Bolen
Cancer Research. 2010496 Citations
SIRT3 Deacetylates Mitochondrial 3-Hydroxy-3-Methylglutaryl CoA Synthase 2 and Regulates Ketone Body Production
Tadahiro Shimazu, Matthew D. Hirschey, Lan Hua, Kristin E. Dittenhafer‐Reed, Bjoern Schwer, David B. Lombard, Li Yu, Jakob Bunkenborg, Frederick W. Alt, John M. Denu, Matthew P. Jacobson, Eric Verdin
Cell Metabolism. 2010482 CitationsOPEN ACCESS
Results from a multicenter, open-label, pivotal phase II study of chidamide in relapsed or refractory peripheral T-cell lymphoma
Yue Shi, Mei Dong, Xiaoting Hong, Wen Zhang, J. Feng, Jing-Zhong Zhu, Li Yu, Xiao Ke, He Huang, Z. Shen, Yun Fan, W. Li, Xiaohong Zhao, Jianyong Qi, He Huang, Daobin Zhou, Zhengwen Ning, Xianping Lu
Annals of Oncology. 2015402 Citations
Gr-1+ Myeloid Cells Derived from Tumor-Bearing Mice Inhibit Primary T Cell Activation Induced Through CD3/CD28 Costimulation
Sergei Kusmartsev, Li Yu, Shu‐Hsia Chen
S38008053. 2000354 Citations
Related on ScholarIQ
Jiangnan University
Institution
Aberrant CpG-island methylation has non-random and tumour-type–specific patterns
Paper
Evaluation of the Proteasome Inhibitor MLN9708 in Preclinical Models of Human Cancer
Paper
SIRT3 Deacetylates Mitochondrial 3-Hydroxy-3-Methylglutaryl CoA Synthase 2 and Regulates Ketone Body Production
Paper
Results from a multicenter, open-label, pivotal phase II study of chidamide in relapsed or refractory peripheral T-cell lymphoma
Paper
Gr-1+ Myeloid Cells Derived from Tumor-Bearing Mice Inhibit Primary T Cell Activation Induced Through CD3/CD28 Costimulation
Paper